Avantor, Inc. (NYSE:AVTR) Receives $11.39 Consensus PT from Brokerages

Shares of Avantor, Inc. (NYSE:AVTR) have earned an average recommendation of “Hold” from the fifteen analysts that are covering the stock, MarketBeat reports. Two research analysts have rated the stock with a sell recommendation, ten have assigned a hold recommendation and three have issued a buy recommendation on the company. The average 1-year target price among analysts that have issued a report on the stock in the last year is $11.3929.

Several research analysts have weighed in on the company. Morgan Stanley set a $10.00 price objective on Avantor in a research report on Friday, February 13th. TD Cowen reissued a “hold” rating on shares of Avantor in a research report on Thursday, February 12th. Stifel Nicolaus set a $10.00 price objective on Avantor in a research report on Thursday, February 12th. Wall Street Zen raised Avantor from a “hold” rating to a “buy” rating in a research report on Saturday. Finally, Robert W. Baird set a $11.00 price objective on Avantor in a research report on Thursday, February 12th.

Avantor Trading Up 2.4%

Shares of Avantor stock opened at $8.17 on Friday. The stock has a fifty day simple moving average of $8.04 and a 200 day simple moving average of $10.17. Avantor has a 12-month low of $7.26 and a 12-month high of $15.93. The company has a market capitalization of $5.57 billion, a P/E ratio of -10.08, a price-to-earnings-growth ratio of 4.65 and a beta of 0.94. The company has a current ratio of 1.76, a quick ratio of 1.17 and a debt-to-equity ratio of 0.68.

Avantor (NYSE:AVTR) last announced its quarterly earnings results on Wednesday, April 29th. The company reported $0.17 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.16 by $0.01. Avantor had a positive return on equity of 9.95% and a negative net margin of 8.42%.The business had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.54 billion. During the same quarter in the prior year, the company posted $0.23 earnings per share. Avantor’s revenue was up .0% compared to the same quarter last year. On average, sell-side analysts anticipate that Avantor will post 0.79 earnings per share for the current fiscal year.

Insider Transactions at Avantor

In other news, Director Sanjeev K. Mehra purchased 125,000 shares of the company’s stock in a transaction dated Tuesday, March 10th. The shares were purchased at an average price of $8.01 per share, with a total value of $1,001,250.00. Following the transaction, the director directly owned 475,000 shares of the company’s stock, valued at approximately $3,804,750. This represents a 35.71% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Simon Dingemans purchased 25,000 shares of the company’s stock in a transaction dated Friday, May 1st. The shares were purchased at an average cost of $8.14 per share, for a total transaction of $203,500.00. Following the transaction, the director directly owned 25,000 shares in the company, valued at approximately $203,500. The trade was a ? increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders bought 310,000 shares of company stock worth $2,685,950 over the last quarter. 0.28% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the company. Royal Bank of Canada lifted its holdings in Avantor by 104.3% during the 1st quarter. Royal Bank of Canada now owns 203,738 shares of the company’s stock worth $3,302,000 after purchasing an additional 104,022 shares in the last quarter. Empowered Funds LLC lifted its holdings in Avantor by 40.3% during the 1st quarter. Empowered Funds LLC now owns 17,659 shares of the company’s stock worth $286,000 after purchasing an additional 5,075 shares in the last quarter. Cetera Investment Advisers lifted its holdings in Avantor by 40.2% during the 2nd quarter. Cetera Investment Advisers now owns 40,289 shares of the company’s stock worth $542,000 after purchasing an additional 11,543 shares in the last quarter. Quantbot Technologies LP purchased a new stake in Avantor during the 2nd quarter worth about $232,000. Finally, Arrowstreet Capital Limited Partnership lifted its holdings in Avantor by 214.9% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 124,076 shares of the company’s stock worth $1,670,000 after purchasing an additional 84,679 shares in the last quarter. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Avantor Company Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.